Another example of an approach to restoring efferocytosis is by disrupting “don’t-eat-me” signaling using anti-CD47 or anti-SIRPα monoclonal antibodies to drive resolution and mitigate atherosclerosis [50,51]. The gene discussed is SIRPA; the disease is atherosclerosis.